Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV001819385 | SCV002067556 | uncertain significance | not specified | 2018-11-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003514530 | SCV004313325 | uncertain significance | Warts, hypogammaglobulinemia, infections, and myelokathexis | 2022-12-27 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C15"). ClinVar contains an entry for this variant (Variation ID: 1336899). This variant has not been reported in the literature in individuals affected with CXCR4-related conditions. This variant is present in population databases (rs779760942, gnomAD 0.003%). This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 249 of the CXCR4 protein (p.Phe249Leu). |